
M&A
Corporate Law
Commercial Law
Private Equity
Healthcare
Pharmaceuticals
Dispute Resolution
Litigation
Securities Litigation
Michal Jašek is a Partner at Clifford Chance, based in Prague. He specializes in M&A, corporate, and commercial law, with a focus on private equity, industrial, energy, infrastructure, and retail sectors. Michal has a particular interest in healthcare and pharmaceuticals. He has been involved in significant transactions, including the sale of regional life insurance businesses and large-scale IPOs. Michal holds a Master’s degree from Charles University, Prague, and an LL.M. from the University of Sydney. His extensive experience and expertise make him a valuable asset to his clients in the Czech Republic and beyond.
Corporate and M&A
Banking and Financial Services
Dispute Resolution and Litigation
Capital Markets and Structured Finance

- Carlyle acquired the target/assets in an acquisition. Date of the transaction is not available. - Deal value was 4200000000. Sector: Technology; Location: Europe. - On the acquirer side, legal advice was provided by a team including Nicholas Kinnersley, Miloš Felgr, Dominik Vojta, Lewis Whyte, Joshua Malek, Michal Jašek, Nigel Wellings, Veronika Kinclová, Tomáš Procházka, Stanislav Holec, Nikola Svobodová, Sebastian de Boer, Petr Ryšina, Matěj Pavlík, Natálie Kurková, Dávid Herich, Šimon Pavlas, Edward Page, Petr Šebesta, Archie Zverev, Moritz Petersen, Nadine Neumeier, Tobias Born, Benjamin Wollweber.
Jul 30 2025
4B
Finance

Senior Associate
2025 – Unknown
Senior Associate / Seniorní advokát
2008 – 2024

- Allwyn acquired the target/assets in an acquisition. Date of the transaction is not available. - Deal value was 3300000000. Sector: Gaming; Location: Europe. - On the acquirer side, legal advice was provided by a team including Tomáš Borčin, Michal Jašek, Alex Cook, Tomáš Procházka, Stanislav Holec, Miloš Felgr, Hana Čekalová, Tomáš Kubala, Edward Page, Archie Zverev, Dominik Vojta, Veronika Kinclová, Nikola Svobodová, Matěj Pavlík, Petr Ryšina, Radek Sikora, Natálie Kurková.
Jan 24 2025
3B
M&A
Dec 1

2 min
2010